MARKET

EBS

EBS

Emergent Biosolutions Inc
NYSE
11.90
-0.15
-1.24%
After Hours: 11.81 -0.1 -0.80% 19:17 12/05 EST
OPEN
12.15
PREV CLOSE
12.05
HIGH
12.24
LOW
11.85
VOLUME
696.25K
TURNOVER
--
52 WEEK HIGH
13.41
52 WEEK LOW
4.020
MARKET CAP
624.99M
P/E (TTM)
9.20
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EBS last week (1124-1128)?
Weekly Report · 5d ago
Emergent BioSolutions (NYSE:EBS) Takes On Some Risk With Its Use Of Debt
Simply Wall St · 11/27 10:14
Weekly Report: what happened at EBS last week (1117-1121)?
Weekly Report · 11/24 09:59
Weekly Report: what happened at EBS last week (1110-1114)?
Weekly Report · 11/17 09:59
Emergent BioSolutions Announces Board Member Retirement
TipRanks · 11/12 21:48
Press Release: Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
Dow Jones · 11/12 21:01
Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS), Emergent Biosolutions (EBS) and Ginkgo Bioworks Holdings (DNA)
TipRanks · 11/10 11:30
Weekly Report: what happened at EBS last week (1103-1107)?
Weekly Report · 11/10 09:58
More
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Webull offers Emergent Biosolutions Inc stock information, including NYSE: EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EBS stock methods without spending real money on the virtual paper trading platform.